| 1 |
High-Dose Versus Low-Dose Pitavastatin in Japanese Patients With Stable Coronary Artery Disease (REAL-CAD)
Isao Taguchi et al. · Circulation
Open access |
7 May 2018 |
246 |
| 2 |
Ezetimibe Lipid-Lowering Trial on Prevention of Atherosclerotic Cardiovascular Disease in 75 or Older (EWTOPIA 75)
Yasuyoshi Ouchi et al. · Circulation
Open access |
22 Aug 2019 |
227 |
| 3 |
Drug-Induced Long-QT Syndrome Associated With a Subclinical SCN5A Mutation
Naomasa Makita, Minoru Horie, Takeshi Nakamura et al. · Circulation
Open access |
3 Sep 2002 |
178 |
| 4 |
Significance of reduced uptake of iodinated fatty acid analogue for the evaluation of patients with acute chest pain
Yuko Kawai, Eriko Tsukamoto, Yoichi Nozaki et al. · Journal of the American College of Cardiology
Open access |
Dec 2001 |
136 |
| 5 |
Differential metabolic effects of distinct statins
Kwang Kon Koh, Ichiro Sakuma, Michael J. Quon · Atherosclerosis
|
3 Nov 2010 |
130 |
| 6 |
Inflammatory and metabolic mechanisms underlying the calcific aortic valve disease
Kyoung Im Cho, Ichiro Sakuma, Il Suk Sohn et al. · Atherosclerosis
|
25 Aug 2018 |
126 |
| 7 |
Target International Normalized Ratio Values for Preventing Thromboembolic and Hemorrhagic Events in Japanese Patients With Non-Valvular Atrial Fibrillation
Hiroshi Inoue et al. · Circulation Journal
Open access |
2013 |
123 |
| 8 |
Randomized trial of angiotensin II-receptor blocker vs. dihydropiridine calcium channel blocker in the treatment of paroxysmal atrial fibrillation with hypertension (J-RHYTHM II Study)
Takeshi Yamashita et al. · EP Europace
Open access |
10 Dec 2010 |
117 |
| 9 |
Antiatherosclerotic and Anti-Insulin Resistance Effects of Adiponectin: Basic and Clinical Studies
Seung Hwan Han, Ichiro Sakuma, Eak Kyun Shin et al. · Progress in Cardiovascular Diseases
|
Sep 2009 |
116 |
| 10 |
α9 Integrin and Its Ligands Constitute Critical Joint Microenvironments for Development of Autoimmune Arthritis
Masashi Kanayama, Daisuke Kurotaki, Junko O. Morimoto et al. · The Journal of Immunology
|
Jun 2009 |
91 |
| 11 |
How to control residual cardiovascular risk despite statin treatment: Focusing on HDL–cholesterol
Soo Lim, Yae Min Park, Ichiro Sakuma et al. · International Journal of Cardiology
|
12 Apr 2012 |
66 |
| 12 |
Impact of Gender on the Prognosis of Patients With Nonvalvular Atrial Fibrillation
Hiroshi Inoue et al. · The American Journal of Cardiology
|
25 Dec 2013 |
61 |
| 13 |
Significant differential effects of omega-3 fatty acids and fenofibrate in patients with hypertriglyceridemia
Kwang Kon Koh, Michael J. Quon, Kwen-Chul Shin et al. · Atherosclerosis
|
20 Nov 2011 |
61 |
| 14 |
Hypertriglyceridemia and Cardiovascular Diseases: Revisited
Seung Hwan Han, Stephen James Nicholls, Ichiro Sakuma et al. · Korean Circulation Journal
Open access |
2016 |
59 |
| 15 |
Omega-3 fatty acid therapy dose-dependently and significantly decreased triglycerides and improved flow-mediated dilation, however, did not significantly improve insulin sensitivity in patients with hypertriglyceridemia
Pyung Chun Oh, Kwang Kon Koh, Ichiro Sakuma et al. · International Journal of Cardiology
|
8 Aug 2014 |
54 |
| 16 |
Differential metabolic effects of rosuvastatin and pravastatin in hypercholesterolemic patients
Kwang Kon Koh, Michael J. Quon, Ichiro Sakuma et al. · International Journal of Cardiology
|
26 Dec 2011 |
53 |
| 17 |
Effect of Intensive Lipid-Lowering Therapy With Rosuvastatin on Progression of Carotid Intima-Media Thickness in Japanese Patients
Ryuji Nohara, Hiroyuki Daida, Mitsumasa Hata et al. · Circulation Journal
Open access |
16 Nov 2011 |
51 |
| 18 |
The EXPAND study: Efficacy and safety of rivaroxaban in Japanese patients with non-valvular atrial fibrillation
Hiroaki Shimokawa et al. · International Journal of Cardiology
Open access |
3 Feb 2018 |
48 |
| 19 |
Use of 123 I-BMIPP single-photon emission tomography to estimate areas at risk following successful revascularization in patients with acute myocardial infarction
Yuko Kawai, Eriko Tsukamoto, Yoichi Nozaki et al. · European Journal of Nuclear Medicine and Molecular Imaging
|
29 Sep 1998 |
42 |
| 20 |
Efficacy and safety of sitagliptin treatment in older adults with moderately controlled type 2 diabetes: the STREAM study
Mototsugu Nagao et al. · Scientific Reports
Open access |
4 Jan 2023 |
41 |
| 21 |
Statins and Renin-Angiotensin System Inhibitor Combination Treatment to Prevent Cardiovascular Disease
Hae‐Young Lee, Ichiro Sakuma, Sang‐Hyun Ihm et al. · Circulation Journal
Open access |
2014 |
40 |
| 22 |
Impact of Weekly Teriparatide on the Bone and Mineral Metabolism in Hemodialysis Patients With Relatively Low Serum Parathyroid Hormone: A Pilot Study
Junya Yamamoto, Daigo Nakazawa, Saori Nishio et al. · Therapeutic Apheresis and Dialysis
|
18 Jun 2019 |
39 |
| 23 |
Coexistence of Visceral Fat and Multiple Risk Factor Accumulations is Strongly Associated with Coronary Artery Disease in Japanese (The VACATION-J Study)
Aki Hiuge-Shimizu, Ken Kishida, Tohru Funahashi et al. · Journal of Atherosclerosis and Thrombosis
Open access |
2012 |
39 |
| 24 |
Long-term Outcomes of Anterior Spinal Fusion for Treating Thoracic Adolescent Idiopathic Scoliosis Curves
Hideki Sudo, Manabu Ito, Kiyoshi Kaneda et al. · Spine
|
20 Nov 2012 |
38 |
| 25 |
Ipragliflozin and sitagliptin differentially affect lipid and apolipoprotein profiles in type 2 diabetes: the SUCRE study
Mototsugu Nagao, Junichi Sasaki, Kyoko Tanimura‐Inagaki et al. · Cardiovascular Diabetology
Open access |
8 Feb 2024 |
37 |
| 26 |
Independent and Distinct Associations of FABP4 and FABP5 With Metabolic Parameters in Type 2 Diabetes Mellitus
Masato Furuhashi, Ichiro Sakuma, Takeshi Morimoto et al. · Frontiers in Endocrinology
Open access |
23 Sep 2020 |
36 |
| 27 |
Treatment with anagliptin, a DPP-4 inhibitor, decreases FABP4 concentration in patients with type 2 diabetes mellitus at a high risk for cardiovascular disease who are receiving statin therapy
Masato Furuhashi, Ichiro Sakuma, Takeshi Morimoto et al. · Cardiovascular Diabetology
Open access |
15 Jun 2020 |
35 |
| 28 |
Effect of Long-Term Intensive Lipid-Lowering Therapy With Rosuvastatin on Progression of Carotid Intima-Media Thickness
Ryuji Nohara, Hiroyuki Daida, Mitsumasa Hata et al. · Circulation Journal
Open access |
2013 |
35 |
| 29 |
Potentially important considerations in choosing specific statin treatments to reduce overall morbidity and mortality
Soo Lim, Ichiro Sakuma, Michael J. Quon et al. · International Journal of Cardiology
|
16 Nov 2012 |
35 |
| 30 |
Vascular and metabolic effects of ezetimibe combined with simvastatin in patients with hypercholesterolemia
Kwang Kon Koh, Pyung Chun Oh, Ichiro Sakuma et al. · International Journal of Cardiology
|
11 Jul 2015 |
34 |
| 31 |
Effects of fenofibrate therapy on circulating adipocytokines in patients with primary hypertriglyceridemia
Kwang Kon Koh, Michael J. Quon, Soo Lim et al. · Atherosclerosis
|
30 Oct 2010 |
33 |
| 32 |
Important factors in left atrial posterior wall isolation using 28‐mm cryoballoon ablation for persistent atrial fibrillation—Block line or isolation area?
Tadafumi Nanbu, Akihiko Yotsukura, George Suzuki et al. · Journal of Cardiovascular Electrophysiology
|
20 Nov 2019 |
32 |
| 33 |
Frequency and time course of reocclusion and restenosis in coronary artery occlusions after balloon angioplasty versus wiktor stent implantation: results from the Mayo-Japan Investigation for Chronic Total Occlusion (MAJIC) Trial
Hideo Tamai, Peter B. Berger, Etsuo Tsuchikane et al. · American Heart Journal
|
Mar 2004 |
32 |
| 34 |
Controversies in the 2017 ACC/AHA Hypertension Guidelines: Who Can Be Eligible for Treatments Under the New Guidelines? ― An Asian Perspective ―
Sang‐Hyun Ihm, George L. Bakris, Ichiro Sakuma et al. · Circulation Journal
Open access |
28 Dec 2018 |
31 |
| 35 |
How to balance cardiorenometabolic benefits and risks of statins
Soo Lim, Pyung Chun Oh, Ichiro Sakuma et al. · Atherosclerosis
|
16 Jun 2014 |
31 |
| 36 |
Small Dense Low-Density Lipoprotein Cholesterol and Cardiovascular Risk in Statin-Treated Patients with Coronary Artery Disease
Junnichi Ishii et al. · Journal of Atherosclerosis and Thrombosis
Open access |
8 Dec 2021 |
28 |
| 37 |
Combination Pravastatin and Valsartan Treatment Has Additive Beneficial Effects to Simultaneously Improve Both Metabolic and Cardiovascular Phenotypes Beyond That of Monotherapy With Either Drug in Patients With Primary Hypercholesterolemia
Kwang Kon Koh, Soo Lim, Hanul Choi et al. · Diabetes
Open access |
18 Jul 2013 |
28 |
| 38 |
Investigation of Gastric and Duodenal Mucosal Defects Caused by Low-dose Aspirin in Patients With Ischemic Heart Disease
Hiroaki Nema, Mototsugu Kato, Takehiko Katsurada et al. · Journal of Clinical Gastroenterology
|
16 Jan 2009 |
27 |
| 39 |
Intensive Lipid-Lowering Therapy for Slowing Progression as Well as Inducing Regression of Atherosclerosis in Japanese Patients
Tsutomu Yamazaki, Ryuji Nohara, Hiroyuki Daida et al. · International Heart Journal
Open access |
2013 |
27 |
| 40 |
Optimal target of LDL cholesterol level for statin treatment: challenges to monotonic relationship with cardiovascular events
Masashi Sakuma, Satoshi Iimuro, Tomohiro Shinozaki et al. · BMC Medicine
Open access |
14 Nov 2022 |
25 |
| 41 |
Combining Potent Statin Therapy with Other Drugs to Optimize Simultaneous Cardiovascular and Metabolic Benefits while Minimizing Adverse Events
Kwang Kon Koh, Ichiro Sakuma, Kazunori Shimada et al. · Korean Circulation Journal
Open access |
12 Dec 2016 |
25 |
| 42 |
Clinical risk factors of stroke and major bleeding in patients with non-valvular atrial fibrillation under rivaroxaban: the EXPAND Study sub-analysis
Ichiro Sakuma, Shinichiro Uchiyama, Hirotsugu Atarashi et al. · Heart and Vessels
Open access |
24 May 2019 |
24 |
| 43 |
Caveats to aggressive lowering of lipids by specific statins
Kwang Kon Koh, Soo Lim, Ichiro Sakuma et al. · International Journal of Cardiology
|
16 Oct 2011 |
24 |
| 44 |
Endoscopic survey of low‐dose‐aspirin‐induced gastroduodenal mucosal injuries in patients with ischemic heart disease
Hiroaki Nema, Mototsugu Kato, Takehiko Katsurada et al. · Journal of Gastroenterology and Hepatology
|
Dec 2008 |
24 |
| 45 |
Role of Left Ventricular Regional Diastolic Abnormalities for Global Diastolic Dysfunction in Patients with Hypertrophic Cardiomyopathy
Kazutomo Goto, Taisei Mikami, Hisao Onozuka et al. · Journal of the American Society of Echocardiography
|
Jul 2006 |
24 |
| 46 |
Differential Metabolic Actions of Specific Statins: Clinical and Therapeutic Considerations
Soo Lim, Ichiro Sakuma, Michael J. Quon et al. · Antioxidants and Redox Signaling
Open access |
8 Aug 2013 |
24 |
| 47 |
Best Treatment Strategies With Statins to Maximize the Cardiometabolic Benefits
Kyoung Im Cho, Ichiro Sakuma, Il Suk Sohn et al. · Circulation Journal
Open access |
2018 |
23 |
| 48 |
Does Treatment of Impaired Glucose Tolerance Improve Cardiovascular Outcomes in Patients with Previous Myocardial Infarction?
ABC investigators et al. · Cardiovascular Drugs and Therapy
|
Aug 2017 |
22 |
| 49 |
Diagnostic Value of 123I-Betamethyl-p-Iodophenyl-Pentadecanoic Acid (BMIPP) Single Photon Emission Computed Tomography (SPECT) in Patients With Chest Pain-Comparison With Rest-Stress 99mTc-Tetrofosmin SPECT and Coronary Angiography-
Yuko Kawai, Koichi Morita, Yoichi Nozaki et al. · Circulation Journal
Open access |
2004 |
22 |
| 50 |
Comparison of 5-Year Outcomes in Patients With and Without Unprotected Left Main Coronary Artery Disease After Treatment With Sirolimus-Eluting Stents
Mamoru Toyofuku, Takeshi Kimura, Takeshi Morimoto et al. · JACC: Cardiovascular Interventions
Open access |
Jul 2013 |
22 |